ArticleFrontiers in oncology2025

Prognostic factors and treatment outcomes in EGFR-mutated NSCLC with malignant pleural effusion: focus on intrathoracic chemotherapy and EGFR-TKI therapy.

Zhuohao Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.